Data

Data Bridge Market Research analyses that the North America lymphedema treatment market will grow at a CAGR of 9.7% during the forecast period of 2022 to 2029. Industry Analysis Mutations may cause primary lymphedema in some of the genes involved in developing the lymphatic system. These faulty genes interfere with the lymphatic system's development, undermining its ability to drain fluid properly. Secondary lymphedema has a number of possible causes, including cancer surgery, radiation therapy, infections, inflammatory conditions, cardiovascular diseases, injury, and trauma The rising prevalence of  cancers  and increasing health expenditure have accelerated the need to treat lymphedema in healthcare facilities. The surge in innovations and technologies is also propelling the market's growth. North America lymphedema treatment market is growing in the forecast year due to the rising players in the market and the availability of advanced imaging products. Along with thi...